Christine Murray
General Counsel at CYTOKINETICS, INCORPORATED
Net worth: 1 837 $ as of 30/03/2024
Profile
Christine Murray is currently the Senior Vice President-Regulatory & Quality at Cytokinetics, Inc. She previously worked as an Independent Director at Eiger BioPharmaceuticals, Inc. from 2019 to 2024.
Prior to that, she held the position of Vice President-Regulatory Affairs at Achaogen, Inc. from 2011 to 2015.
She also served as the Vice President-Global Regulatory Affairs at Horizon Pharmaceutical LLC from 2015 to 2017 and at Raptor Pharmaceuticals, Inc. from 2015 to 2017.
From 2018 to 2021, she was the Senior Vice President-Global Regulatory Affairs at Ultragenyx Pharmaceutical, Inc. Ms. Murray completed her undergraduate studies at The University of Liverpool and her graduate studies at Newcastle University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 19/11/2023 | 367 ( 0.02% ) | 1 837 $ | 30/03/2024 |
Christine Murray active positions
| Companies | Position | Start |
|---|---|---|
| CYTOKINETICS, INCORPORATED | General Counsel | 31/03/2023 |
Former positions of Christine Murray
| Companies | Position | End |
|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Director/Board Member | 14/03/2024 |
| ULTRAGENYX PHARMACEUTICAL INC. | General Counsel | 31/08/2021 |
Raptor Pharmaceuticals, Inc.
 Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Corporate Officer/Principal | 31/01/2017 |
| RAPTOR PHARMACEUTICAL CORP | General Counsel | 31/12/2016 |
| ACHAOGEN | General Counsel | 01/01/2015 |
Training of Christine Murray
| The University of Liverpool | Undergraduate Degree |
| Newcastle University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| CYTOKINETICS, INCORPORATED | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Horizon Pharmaceutical LLC
 Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Health Technology |
- Stock Market
- Insiders
- Christine Murray
